Management of rheumatoid arthritis in Spain (emAR II). Clinical characteristics of the patients
- PMID: 22608957
- DOI: 10.1016/j.reuma.2012.03.009
Management of rheumatoid arthritis in Spain (emAR II). Clinical characteristics of the patients
Abstract
Background: There is a wide variability in the diagnostic and therapeutic methods in rheumatoid arthritis (AR) in Spain, according to prior studies. The quality of care could benefit from the application of appropriate clinical practice standards; we present a study on the variability of clinical practice.
Methods: Descriptive review of clinical records (CR) of patients aged 16 or older diagnosed with RA, selected by stratified sampling of the Autonomous Communities in two stages per Hospital Center and patient. Collected analysis of sociodemographic data, evolution, follow-up, joint count, reactants, function, job history, Visual Analogue Scales (VAS) and other.
Results: We obtained valid information of 1,272 RA patients. The ESR, CRP and rheumatoid factor (RF) were regularly used parameters. The percentages of missing data in tender (TJN) and swollen (SJN) joint counts were 8.2% and 9.6% respectively; regarding the VAS we found 53.6% (patient), 59.1% (pain), and 72% in the physician VAS.
Conclusions: Despite having clinical practice guidelines on RA, there still exists a significant variability in RA management in our country.
Copyright © 2011 Elsevier España, S.L. All rights reserved.
Similar articles
-
Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?J Rheumatol. 2006 Jul;33(7):1243-6. Epub 2006 Apr 15. J Rheumatol. 2006. PMID: 16622906
-
[Differences in the management of early and established rheumatoid arthritis].Reumatol Clin. 2011 May-Jun;7(3):172-8. doi: 10.1016/j.reuma.2010.08.001. Epub 2011 Feb 23. Reumatol Clin. 2011. PMID: 21794809 Spanish.
-
Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.Semin Arthritis Rheum. 2011 Aug;41(1):81-9. doi: 10.1016/j.semarthrit.2010.09.004. Epub 2010 Dec 17. Semin Arthritis Rheum. 2011. PMID: 21168187
-
Treating to target in rheumatoid arthritis - challenges and opportunities.Bull Hosp Jt Dis (2013). 2013;71(3):214-7. Bull Hosp Jt Dis (2013). 2013. PMID: 24151948 Review.
-
Rheumatoid arthritis: clinical guideline 2003.S Afr Med J. 2003 Dec;93(12 Pt 2):991-1012. S Afr Med J. 2003. PMID: 14763411 Review. No abstract available.
Cited by
-
Real-World Evidence for Baricitinib in the Treatment of Rheumatoid Arthritis in Spain: A Systematic Literature Review.Adv Ther. 2025 May;42(5):2403-2428. doi: 10.1007/s12325-025-03161-3. Epub 2025 Mar 22. Adv Ther. 2025. PMID: 40120028 Free PMC article.
-
A European chart review study on early rheumatoid arthritis treatment patterns, clinical outcomes, and healthcare utilization.Rheumatol Int. 2015 Nov;35(11):1837-49. doi: 10.1007/s00296-015-3312-3. Epub 2015 Jul 12. Rheumatol Int. 2015. PMID: 26164150
-
Variability in the frequency of rheumatology consultations in patients with rheumatoid arthritis in Spain.Rheumatol Int. 2016 Nov;36(11):1525-1534. doi: 10.1007/s00296-016-3547-7. Epub 2016 Aug 18. Rheumatol Int. 2016. PMID: 27538838
-
Translational Education.Biomed Hub. 2017 Nov 21;2(Suppl 1):72-78. doi: 10.1159/000481127. eCollection 2017 Nov-Dec. Biomed Hub. 2017. PMID: 31988937 Free PMC article.
-
Synthetic disease-modifying antirheumatic drug prescribing variability in rheumatoid arthritis: a multilevel analysis of a cross-sectional national study.Rheumatol Int. 2015 Nov;35(11):1825-36. doi: 10.1007/s00296-015-3363-5. Epub 2015 Sep 24. Rheumatol Int. 2015. PMID: 26403284
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous